Navigation Links
Odyssey Thera, Inc. Announces New Equity Financing and Initiation of Research Contract with Merck
Date:2/14/2013

SAN RAMON, Calif., Feb. 14, 2013 /PRNewswire/ -- Odyssey Thera, Inc., a privately held biotechnology company, announced today a new equity financing and the initiation of a research service contract with Merck, known as MSD outside the U.S. and Canada.

Additional participants in this financing include HBM Partners, Burrill & Company, and Lonza.  The financing, comprising new funds and debt conversion, totals $2.8M. These funds will be used to support continued advancement and expanded commercialization of Odyssey Thera's technologies and products.

"The support from current and new investors will expedite commercialization of Odyssey Thera technologies," said Dr. John K. Westwick , President and CEO of Odyssey Thera. "We look forward to supporting Merck and other leading discovery and development programs with these validated capabilities."   

About Odyssey Thera, Inc.

Odyssey Thera was founded over ten years ago with the goal of transforming drug discovery through deep cellular analysis. Odyssey's patented technologies measure disease-relevant pathway activity within living human cells. Unprecedented throughput and breadth of high-content assays enables assessment of key signaling nodes as well as the cellular system, allowing for rapid identification of drug candidates with optimal efficacy and safety profiles. The Company's leadership position in fundamental patents, technology, and know-how relating to cellular analysis has led to alliances with Pfizer, Abbott, Merck, the U.S. EPA, and others. To learn more about Odyssey Thera, please visit www.odysseythera.com.


'/>"/>
SOURCE Odyssey Thera, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. HKTU Announces Development of a New Male Enhancement Supplement
2. STAAR Surgical Announces Fourth Quarter 2012 Results Release Date And Conference Call And Webcast
3. United Therapeutics Announces FDA Acceptance of Resubmission of Oral Treprostinil NDA
4. Breckenridge Announces Approval for Pioglitazone Hydrochloride tablets
5. Regulus Announces Timing for Fourth Quarter and Year-End 2012 Financial Results Webcast and Conference Call
6. CryoLife Announces Quarterly Cash Dividend for the First Quarter 2013
7. Xenon Announces Appointment of EVP, Research & Development
8. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
9. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
10. OrbusNeich Announces Favorable Ruling From the European Patent Office
11. Trovagene Announces Commercial Launch Timelines for HPV Carrier and Oncogene Mutation Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):